期刊文献+

PET-CT与腹部增强CT对腹膜转移瘤诊断价值的对比分析 被引量:8

Comparison of ISF-FDG PET-CT and abdomen enhancement CT in diagnosing peritoneal metastases
原文传递
导出
摘要 目的比较^18F-FDGPET-CT与腹部增强CT对腹膜转移瘤的诊断价值。方法2008年1月至2011年5月间对中山大学附属第一医院收治的怀疑腹膜转移瘤的97例患者进行,^18F-FDGPET-CT和腹部增强CT检查.通过病理检查及临床随访最终证实有无腹膜转移瘤.比较两种检查方法对腹膜转移瘤的诊断价值。结果97例患者中,经病理检查(88例)及临床随访(9例)证实77例有腹膜转移.20例无腹膜转移。PET-CT诊断腹膜转移瘤的敏感度为90.9%(70/77).特异度为85.0%(17/20),准确性为89.7%(87/97);出现3例假阳性和7例假阴性。腹部增强CT诊断腹膜转移瘤的敏感度为66.2%(51/77),特异度为80.0%(16/20),准确性为69.1%(67/97);出现4例假阳性和26例假阴性。两种方法诊断准确率的差异有统计学意义(P〈0.05)。结论^18F-FDGPET-CT对于腹膜转移瘤的诊断价值明显高于腹部增强CT。 Objective To compare the diagnostic value of ^18SF-FDG PET-CT with abdomen contrast CT in the diagnosis of peritoneal metastases. Methods Between January 2008 and May 2011, imaging results of 97 patients with suspicious peritoneal metastases were retrospectively reviewed, and all the patients underwent both abdomen contrast CT and ^18SF-FDG PET-CT imaging. Final diagnosis was made by histopathology or follow up. Results Seventy-seven patients were verified as peritoneal metastases after pathological examination (n=88) or follow up (n=9), while the other 20 patients were absent. The sensitivity of ^18SF-FDG PET-CT was 90.9%(70/77), the specificity 85.0%(17/20), and the accuracy 89.7%(87/97). There were 3 false positive and 7 false negative. The sensitivity of contrast CT was 66.2%(51/77), the specificity 80.0%(16/20), and the accuracy 69.1%(67/97). There were 4 false positive and 26 false negative. The difference in diagnostic accuracy was statistically significantly between these two methods (P〈0.05). Conclusion The diagnostic value of ^18sF-FDG PET-CT is significantly higher than that of abdominal enhanced CT for peritoneal metastases.
出处 《中华胃肠外科杂志》 CAS 2012年第7期702-705,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 肿瘤转移 腹膜 正电子发射断层显像术 体层摄影术 X线计算机 诊断 Neoplasm metastases, peritoneal Positron-emission tomography Tomography,X-ray computed Diagnosis
  • 相关文献

参考文献15

  • 1Wang Z, Chen JQ. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol, 2011, l 1 (19) : 1-14.
  • 2Dux M, Richter GM, Hansmann J, et al. Helical hydro-CT for diagnosis and staging of gastric carcinoma. J Comput Assist Tomogr, 1999,23(6) :913-922.
  • 3Sendler A, Dittler HI, Feussner H, et al. Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg, 1995,19(4) :501-508.
  • 4Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med, 2004,45 (9) : 1431-1434.
  • 5王晓燕,张祥松,陈志丰,李子平,李芳,饶国辉,史新冲,胡平.18F-FDGPET/CT诊断腹膜转移瘤的临床价值[J].中华核医学杂志,2010,30(2):98-100. 被引量:7
  • 6董国礼,刘兴华,翟昭华,杨林,黄小华,张小明,唐显映,罗开.多层螺旋CT检查在腹膜转移瘤诊断中的价值[J].放射学实践,2009,24(7):763-766. 被引量:13
  • 7Chamadol N, Wongwiwatchai J, Bhudhisawasd V, et al. Accuracy of spiral CT in preoperative staging of gastric carcinoma: correlation with surgical and pathological findings. J Med Assoc Thai, 2008,91 (3):356-363.
  • 8潘吉勇,李文斌,宋永蔚.血清CA125在胃癌腹膜转移诊断中的临床评价[J].现代生物医学进展,2009,9(5):911-913. 被引量:6
  • 9Low RN, Barone RM, Lacey C, et al. Peritoneal tumor: MR imag/ng with dilute oral barium and intravenous gadolinium- containing contrast agents compared with unenhaneed MR imaging and CT. Radiology, 1997,204(2) :513-520.
  • 10Satoh Y, Ichikawa T, Motosugi U, et al. Diagnosis of peritoneal dissemination: comparison of SF-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AIR Am J Roentgenol, 2011,196(2) :447-453.

二级参考文献48

共引文献80

同被引文献61

  • 1周东雷,郑成竹,胡旭光,李际辉.腹腔镜对不明原因腹水诊断价值研究[J].中国实用外科杂志,2007,27(8):627-629. 被引量:17
  • 2Singnurkar A, Solomon S B, Gcinen M, et al. ^18 F-FDG PET/CT for the prediction and detection of local recurrence after radiofre- quency ablation of malignant lung lesions[J]. J Nucl Med, 2010, 51(12) :1833 -40.
  • 3Kysucan J, Lovecek M, Klos D, et al. Benefit of PET/CT in the preoperative staging in pancreatic carcinomas [ J]. Rozhl Chir, 2010, 89(7) :433 -40.
  • 4Kleinberg L, Hohh A, Fridman E, et al. The diagnostic role of claudins in serous effusions[ J]. Am J Clin Pathol, 2007, 127 (6) :928 -37.
  • 5Zhang M, Jiang X, Zhang M, et al. The Role of ^18F-FDG PET/ CT in the evaluation of Ascites of Undetermined Origin[ J]. J Nucl Med, 2009, 50(4):506- 12.
  • 6Nishiyama Y, Yamamoto Y, Monden T, et al. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumor. Nucl Med Commun, 2005, 26: 895-901.
  • 7Kate K, Nihashi T, Ikeda M, et,al. Limited efficacy of (18) F-FDG PET/CT for differentiation between metastasis- free pancreatic cancer and mass-forming pancreatitis. Clin Nucl Med, 2013,38:417-421.
  • 8Schellenberg D, Quon A, Minn AY, et al. 18FluorodeoxyglucosePET is prognostic of progression-free and overall survival in locallyadvanced pancreas cancer treated with stereotactic radiotherapy. Int J Radiat Oncol BiolPhys, 2010, 77: 1420-1425.
  • 9Hu SL, Yang ZY, Zhou ZR, et al. Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation. Nucl Med Commun, 2013, 34: 533-539.
  • 10Moon SY, Joo KR, So YR, et, al. Predictive Value of Maximum Standardized Uptake Value (SUVmax) on 18F-FDG PET/CT in Patients With Locally Advanced or Metastatic Pancreatic Cancer. Clin Nucl Med, 2013, 38: 778-783.

引证文献8

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部